ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

(b)    On March 18, 2017, Paul M. Bisaro, a member of the Board of Directors (the “Board”) of Zimmer Biomet Holdings, Inc. (the “Company”), notified the Chairman of the Board that he will not stand for reelection at the Company’s 2017 Annual Meeting of Stockholders (the “Annual Meeting”). Mr. Bisaro’s decision not to stand for reelection is not the result of any disagreement with the Company. Mr. Bisaro will continue to serve as a director and as a member of each of the Compensation and Management Development Committee and the Corporate Governance Committee of the Board until his current term expires at the Annual Meeting. The Board intends to reduce its size to eleven members effective upon the expiration of Mr. Bisaro’s term as a director.

About ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH)

Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company’s products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consists of the United States and includes other North, Central and South American markets; EMEA, consists of Europe and includes the Middle East and African markets, and Asia Pacific, consists of Japan and includes other Asian and Pacific markets. Its four product category segments include Americas Spine, Bone Healing Craniomaxillofacial and Thoracic, and Dental.

ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Recent Trading Information

ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) closed its last trading session down -0.98 at 120.40 with 1,005,811 shares trading hands.